Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Pharmacological Research
|
February 6, 2022
Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis
Kai-Wen Cheng, Chih-Hua Tseng, I-Ju Chen, et al.
Plos Biology
|
June 14, 2019
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
Yun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, et al.
Analytical Chemistry
|
May 10, 2017
Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules
Wen-Wei Lin, Yi-An Cheng, Chien-Han Kao, et al.
Bioengineering & Translational Medicine
|
October 1, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy
Bo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.
International Journal of Biological Macromolecules
|
March 7, 2026
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy
Shi-Wei Chao, Bo-Cheng Huang, Shih-Ting Hong, et al.
Journal of Nanobiotechnology
|
February 1, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Yuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.
Scientific Reports
|
July 22, 2021
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy
Wen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, et al.
NPJ Vaccines
|
November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization
En-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
International Journal of Biological Macromolecules
|
February 20, 2025
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
Tzu-Yi Liao, Yen-Ling Liu, Chiao-Yun Chen, et al.
International Journal of Biological Macromolecules
|
February 27, 2026
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events
Bo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Pharmacological Research
|
February 6, 2022
Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis
Kai-Wen Cheng, Chih-Hua Tseng, I-Ju Chen, et al.
Plos Biology
|
June 14, 2019
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
Yun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, et al.
Analytical Chemistry
|
May 10, 2017
Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules
Wen-Wei Lin, Yi-An Cheng, Chien-Han Kao, et al.
Bioengineering & Translational Medicine
|
October 1, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy
Bo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu, et al.
International Journal of Biological Macromolecules
|
March 7, 2026
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy
Shi-Wei Chao, Bo-Cheng Huang, Shih-Ting Hong, et al.
Journal of Nanobiotechnology
|
February 1, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Yuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang, et al.
Scientific Reports
|
July 22, 2021
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy
Wen-Wei Lin, Yun-Chi Lu, Bo-Cheng Huang, et al.
NPJ Vaccines
|
November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization
En-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
International Journal of Biological Macromolecules
|
February 20, 2025
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
Tzu-Yi Liao, Yen-Ling Liu, Chiao-Yun Chen, et al.
International Journal of Biological Macromolecules
|
February 27, 2026
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events
Bo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.
Page
of 3